Everything on Gender & Biology →
Primary documents
- R (Bell) v Tavistock and Portman NHS Foundation Trust [2020] EWHC 3274 (Admin)
Court Filing · 2020
High Court of Justice, Divisional Court (Sharp P, Lewis LJ, Lieven J)
Divisional Court held under-16s highly unlikely to be Gillick competent to consent to puberty blockers and issued a declaration/guidance; records GIDS referral surge: 'In 2009, 97…
- Rapid-onset gender dysphoria in adolescents and young adults: A study of parental reports (2018)
Peer-Reviewed Study · 2018
Littman L
Original ROGD parent-report study (n=256), recruited from three websites; descriptive, hypothesis-generating design.
- Recommendation on medical treatment methods for dysphoria associated with variations in the gender identity of minors (2020)
Government Record · 2020
Council for Choices in Health Care in Finland (COHERE/PALKO)
Finland's June 2020 national recommendation: psychosocial support first-line for minors; cross-sex hormones no earlier than 16; no surgeries on minors; gender reassignment of minors characterised as…
- Reply Brief of Plaintiff-Appellant, Mosley v. Emerson, No. COA26-132 (2026)
Court Filing · 2026
Prisha Mosley, by counsel
Mosley’s reply argues that HB 805 revived malpractice and negligent-infliction claims and that she deserves trial on fraud, facilitating fraud, and civil conspiracy. It is party…
- Researchers slam HHS report on gender-affirming care for youth (2025)
News Report · 2025
Science (news), quoting AAP response
Documents the American Academy of Pediatrics' rejection of the May 2025 HHS report and other researchers' criticism – the response side on the HHS report.
- Risk of pseudotumor cerebri added to labeling for gonadotropin-releasing hormone agonists (2022)
Government Record · 2022
U.S. Food and Drug Administration
FDA added a pseudotumor cerebri (idiopathic intracranial hypertension) warning to all GnRH agonist pediatric labeling (Lupron Depot-Ped, Fensolvi, Synarel, Supprelin LA, Triptodur) after six cases (ages…
- S. 2357, Protect Children’s Innocence Act, 118th Congress (2023)
Government Record · 2023
Sen. J. D. Vance
S. 2357 was introduced by Senator J. D. Vance on July 18, 2023 and referred to the Senate Judiciary Committee. No Senate or House passage was…
- Senator Wiener’s Historic Bill to Provide Refuge for Trans Kids and Their Families Signed into Law (2022)
Government Record · 2022
Office of California Senator Scott Wiener
The sponsor’s official statement describes SB 107’s limits on enforcing out-of-state removal laws, subpoenas, arrests, and extradition connected to lawful California gender-affirming care. The refuge law…
- Sex reassignment at birth. Long-term review and clinical implications (1997)
Peer-Reviewed Study · 1997
Milton Diamond and H. Keith Sigmundson
The 1997 article reports that the individual later rejected the assigned sex of rearing and lived as a male from puberty onward. It is a long-term…
- Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK (2021)
Peer-Reviewed Study · 2021
Carmichael P, Butler G, Masic U, et al.
The UK Early Intervention Study (GIDS/UCLH, n=44): no significant psychological-function change on blockers; bone-density z-scores fell; 98% proceeded to cross-sex hormones. CONTRADICTS the book's claim that…
- Sperm characteristics and testicular development in transgender girls and young women on puberty suppression (de Nie et al.) (2025)
Peer-Reviewed Study · 2025
de Nie I, et al.
Study of 214 natal males treated with GnRH agonists (with/without estrogen): full spermatogenesis in only 4.7%, all of whom started blockers at Tanner stage 4+; those…
- Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (SOC8) (2022)
Document · 2022
Coleman E, Radix AE, Bouman WP, et al. (WPATH)
WPATH SOC8 (Sept 2022) added a dedicated adolescent chapter. Draft versions circulated with minimum ages (14 for hormones, 15 mastectomy, 16 breast/17 genital); the published version…
- Statement About Transgender Health Care at VUMC (2022)
Document · 2022
Vanderbilt University Medical Center
VUMC responded that social-media posts and a video misrepresented its care. It stated that parental consent was required and employees could decline morally objectionable care.
- Supprelin LA Prescribing Information (2025)
Government Record · 2025
Endo / U.S. National Library of Medicine
The label identifies central precocious puberty as the approved indication and does not list gender dysphoria. No located company record in this run established marketing of…
- Supreme Court Docket 25-77, Foote v. Ludlow School Committee (2026)
Court Filing · 2026
Supreme Court of the United States
The Supreme Court denied certiorari in Foote on April 20, 2026. The First Circuit’s affirmance of dismissal therefore remained in place, without a Supreme Court merits…
- Susan Thompson Buffett Foundation Form 990, Tax Year 2023
Corporate Filing · 2023
Susan Thompson Buffett Foundation
The Susan Thompson Buffett Foundation’s 2023 return records $301,372 in general operating support to the National LGBTQ Task Force. This ties a Buffett-family foundation to LGBTQ…
- Sweden’s National Board of Health and Welfare: updated recommendations for hormone treatment of minors with gender dysphoria (summary and confirmation) (2022)
Document · 2022
Socialstyrelsen (update 22 February 2022; knowledge support December 2022), via SEGM summary and Lakartidningen
Sweden's NBHW February 2022 update concluded risks of puberty blockers/cross-sex hormones for minors outweigh possible benefits; hormones restricted to research settings/exceptional cases, earliest Tanner stage 3,…
- Sworn Affidavit of Jamie Reed (2023)
Government Record · 2023
Jamie Reed
Reed’s signed, notarized affidavit alleges high patient volume, parental-consent problems, and billing concerns at the Washington University Transgender Center. These are sworn allegations by Reed, not…
- Target Corporation Form 10-Q for Quarter Ended July 29, 2023
Corporate Filing · 2023
Target Corporation
Target’s Q2 2023 Form 10-Q reports total revenue of $24.8 billion, down 4.9%, and a 5.4% comparable-sales decline. The filing does not establish a $10 billion…
- Target Corporation Reports Second Quarter Earnings (2023)
Corporate Filing · 2023
Target Corporation
Target confirms the Q2 sales decline while reporting higher operating income and earnings per share. The release does not substantiate a $10 billion market-value loss or…
- Tawani Charitable Distribution Fund Form 990, Tax Year 2023
Corporate Filing · 2023
Tawani Charitable Distribution Fund
The Tawani Charitable Distribution Fund’s 2023 return records $10,000 in general support to WPATH. It also records $125,000 in general support to Transgender Legal Defense &…
- Tennessee attorney general says seeking clinic’s transgender patient records part of fraud probe (2023)
News Report · 2023
Kimberlee Kruesi and Jonathan Mattise, Associated Press
AP reports the AG’s description of a fraud investigation and the range of patient, billing, personnel, contract, email, and Trans Buddy records demanded. The investigation and…
- Tennessee Senate Bill 1, 113th General Assembly (2023)
Government Record · 2023
Tennessee General Assembly
SB 1 prohibits specified medical procedures for minors for the statutory purposes and authorizes injunctive relief, disgorgement, and a $25,000 civil penalty per violation. It took…
- Testosterone Cypionate injection – label (Pediatric Use)
Government Record
DailyMed (U.S. National Library of Medicine)
Testosterone cypionate labeling: indicated for male hypogonadism (no gender-dysphoria indication at any age); pediatric safety/effectiveness under 12 not established; warns androgens in children may accelerate bone…